Companies / BOC Sciences / Izuralimab
BOC Sciences

Izuralimab | BOC Sciences

Izuralimab is a bispecific antibody that targets PD-1 (PDCD1) and ICOS (inducible T-cell costimulator, CD278).

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.